LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
2.39
EUR
0.16
EUR
7.24 %
29.05.2026
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 2.61 USD | 0.06 USD | 2.43 % |
|---|
| Vortag | 2.55 USD | Datum | 27.05.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 106.92% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 101.78% | |
| 21Shares Injective Staking ETP | CH1360612134 | 68.39% | |
| 21Shares Bittensor ETP | CH1495416971 | 41.89% | |
| 21Shares Ondo ETP | CH1396389921 | 38.83% | |
| 21Shares Artificial Superintelligence Alliance ETP | CH1480821375 | 38.58% | |
| 21Shares Render ETP | CH1396343266 | 35.08% | |
| 21Shares Pendle ETP | CH1495416997 | 15.31% | |
| 21Shares Jupiter ETP | CH1480821383 | 10.80% | |
| 21Shares Dogecoin ETP | CH1431521033 | 3.72% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Canton Network ETP | CH1503127917 | 68.79% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 59.31% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 21.61% | |
| 21Shares Toncoin Staking ETP | CH1297762812 | 7.06% | |
| 21Shares Render ETP | CH1396343266 | 3.06% | |
| 21Shares Injective Staking ETP | CH1360612134 | -16.72% | |
| 21Shares Bittensor ETP | CH1495416971 | -17.73% | |
| 21Shares Jupiter ETP | CH1480821383 | -33.43% | |
| 21Shares Dogecoin ETP | CH1431521033 | -36.95% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -40.20% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | 10.15% | |
| 21Shares Binance BNB ETP | CH0496454155 | -9.48% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -18.23% | |
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | -23.83% | |
| 21Shares Ethereum Staking ETP | CH0454664027 | -24.51% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -31.73% | |
| 21Shares Dogecoin ETP | CH1431521033 | -56.36% | |
| 21Shares Injective Staking ETP | CH1360612134 | -65.22% | |
| 21Shares Sui Staking ETP | CH1360612159 | -74.62% | |
| 21Shares Immutable ETP | CH1360612142 | -75.84% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 134.44% | |
| 21Shares Stellar ETP | CH1109575535 | 72.61% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 62.93% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 20.34% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 6.89% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 627’689.32 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 29.05.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 61.15 | |
| Performance 2 Jahre | 31.84 | |
| Performance 3 Jahre | 6.46 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |